on 26 Sep 2023
Last Applicant/ Owned by
SUZHOU INDUSTRIAL PARK, SUZHOU
JIANGSU
CN
215000
Serial Number
97412748 filed on 16th May 2022
Registration Number
7172959 registered on 26th Sep 2023
Correspondent Address
Kathryn E. Smith
Filing Basis
1. intent to use
Disclaimer
NO DATA
Chemical preparations for medical purposes, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs sold in bulk, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Read More
Chemical preparations for medical purposes, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs sold in bulk, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; radioactive substances for medical purposes; gases for medical purposes, namely, nitric oxide for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants; solutions for contact lenses; media for bacteriological cultures; medicated sweets; dietetic preparations adapted for medical use; depuratives for the body; diagnostic preparations for veterinary purposes; pesticides; sanitary napkins; cotton for medical purposes; dental abrasives; diapers for pets
No 97412748
No Service/Collective Mark
No ASCNT-20128
Yes
No
No
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
26th Sep 2023 | REGISTERED-PRINCIPAL REGISTER |
26th Sep 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
11th Jul 2023 | PUBLISHED FOR OPPOSITION |
11th Jul 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
21st Jun 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
05th Jun 2023 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
27th May 2023 | EXAMINERS AMENDMENT -WRITTEN |
27th May 2023 | EXAMINERS AMENDMENT E-MAILED |
27th May 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
27th May 2023 | EXAMINER'S AMENDMENT ENTERED |